Kenyan Health Patient Information Leaflet
Biguanide antidiabetic
T2DM when metformin alone is insufficient Clinical selection for Linagliptin/Metformin should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Biguanide antidiabetic. Confirm site-specific dose, duration and monitoring before prescribing.
BD with meals, requires renal-based dose adjustment, and is contraindicated if eGFR <30 mL/min/1.73 m²
[From component Metformin] Lactic acidosis in presence of renal failure; nausea and vomiting; anorexia; diarrhoea; metallic taste; urticaria; decreased vitamin B12 absorption.
Store as labelled. Keep out of reach of children.